Onyx Biotec IPO allotment today: Here are steps to check status on NSE and Mas Services website

Pharmaceutical company Onyx Biotec Limited is expected to declare the IPO share allotment status on Tuesday, November 19, after the successful close of its public offer.

The ₹29.34-crore initial public offering (IPO) of the pharmaceutical company closed for subscription on Monday, November 18. Overall, the NSE SME issue was subscribed to 198 times.

Investors are now waiting for Onyx Biotec IPO share allotment status to be finalised. The successful bidders will be informed by the company through SMS and emails.

Investors who applied for the IPO shares can easily check the allotment status on the websites of the issue registrar, Mas Services Limited, and the NSE.

Here’s how to check Onyx Biotec IPO share allotment status on registrar’s website:

• Visit Mas Services Ltd website at https://www.masserv.com/index.asp
• Select the IPO Allotment Status for Onyx Biotec Limited
• Select either Search on Dp_id/Client id or Search on PAN
• Enter detail
• Click on the ‘Search’ button

It’s important to note that the share allotment status will be available after the finalisation of share allocation by the company.

Steps to check Onyx Biotec Ltd share allotment on the NSE website

• Open the NSE IPO allotment status page: www.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp
• Login with username and password (New investors need to create Login ID and Password)
• Select Onyx Biotec Ltd from the drop down menu for issue names
• Verify PAN details
• Enter IPO application Number
• Click on Submit

Onyx Biotec Ltd IPO subscription details

The IPO Onyx Biotec Ltd was booked around 198 times at the close of subscription on Monday, November 18. The bidding started on Wednesday, November 13, on a strong note as the issue was fully booked within hours of the launch.

Investors placed bids for 63,57,78,000 shares against 32 lakh shares on offer, resulting in an overall booking level of over 198 times, according to the NSE data.

Among investor categories, retail investors booked their quota nearly 119 times. The Non-Institutional Investors’ (NIIs) category was booked 603 times, while the Qualified Institutional Buyers (QIBs) booked their quota over 32 times.

Onyx Biotec IPO offer size, price band and other key details

The ₹29.34-crore Onyx Biotec IPO comprised only a fresh issue of 48.1 lakh shares and there was no Offer-for-Sale (OFS) component. The IPO price band was fixed at ₹58 to ₹61 per share.

Onyx Biotec promoters, including Sanjay Jain, Naresh Kumar and Fateh Pal Singh, held an 88.6% stake in the company ahead of the IPO.

Onyx Biotec IPO listing date has been tentatively fixed as November 21. Shares of Onyx Biotec Limited will be listed on the NSE SME platform, Emerge.

Onyx Biotec key financials

Onyx Biotec reported revenue of ₹10.54 crore for the first quarter of FY25. Profit-after-tax was ₹1.3 crore in the June quarter.

Revenue rose by over 36% to ₹53.87 crore in 2023-24 compared to ₹39.61 crore in FY23. Its net profit grew over 64% to ₹3.03 crore for the fiscal ended March 31, 2024, compared to ₹1.84 crore in the preceding fiscal.

About Onyx Biotec

Onyx Biotec Limited, incorporated in May 2005, is a leading pharma company specialising in manufacturing of sterile water for injections. The firm also works as a contract manufacturer for dry powder injections and dry syrups for both the Indian and overseas pharma companies. The company has two manufacturing units in Solan, Himachal Pradesh.